This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024.
Chartwell RX LLC is the prime contractor for this award, which is not set aside for any particular business type. The company has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at over $7 million, that runs through March 2030. This IDC allows Chartwell RX to manufacture and distribute a wide range of medications to military treatment facilities worldwide. The company has also secured other significant federal contracts, including a $139.7 million delivery order for doxycycline hyclate tablets and amoxicillin trihydrate capsules, and an $8.6 million contract from the Department of Health and Human Services to provide pharmaceutical drugs for the Strategic National Stockpile.
Generated 7/24/24, 9:39 AM